Memberships

MetrioPharm AG

MetrioPharm Memberships

MetrioPharm is now exploring the development of the MP1000 platform in an inhaled dosage form.

Topics: Edison Report, Company Calendar

Background Discussion on MetrioPharm's Preclinical COPD Study

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

MetrioPharm AG

Bleicherweg 10
8002 Zurich

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin